Prevalence of antibody to hepatitis C virus (anti-HCV) by demographic and risk factors among sexually transmitted disease clients, Miami, Florida, January–March, 2001 (n=687)
| Characteristic | Total tested | Anti-HCV+ | Prevalence ratio | p Value |
|---|---|---|---|---|
| *“Don’t know” responses were reclassified as “no.” | ||||
| The following were the number of “don’t know” responses for each variable: Blood transfusion (n=12); blood transfusion before 1992 (n=12); injected drugs (n=1); stuck with a needle with blood on it (n=6); lifetime sexual partners (n=2); diagnosed with an STD (n=1); injected vitamins or medications with used needles (n=4); injected vitamins or medications outside United States (n=13); household contact with HCV+ person (n=181); sexual contact with HCV+ person (n=181); ever been told HIV+ (n=11). | ||||
| Sex | ||||
| Female | 282 | 12 (4.3%) | 1.00 | |
| Male | 405 | 20 (4.9%) | 1.16 | 0.68 |
| Age (years) | ||||
| <30 | 293 | 6 (2.0%) | ||
| ⩾30 | 394 | 26 (6.6%) | 3.26 | 0.005 |
| Race/ethnicity | ||||
| Non-Hispanic white | 43 | 7 (16.3%) | 1.00 | |
| Non-Hispanic black | 255 | 9 (3.5%) | 0.21 | 0.003 |
| Hispanic | 331 | 15 (4.5%) | 0.28 | 0.007 |
| Haitian | 53 | 1 (1.9%) | 0.12 | 0.02 |
| Non-Hispanic other | 5 | 0 (0.0%) | ||
| Education | ||||
| >High school | 206 | 9 (4.4%) | 1.00 | |
| High school | 240 | 9 (3.8%) | 0.86 | 0.74 |
| <High school | 241 | 14 (5.8%) | 1.33 | 0.49 |
| US born | ||||
| No | 382 | 14 (3.7%) | ||
| Yes | 305 | 18 (5.9%) | 1.61 | 0.17 |
| Blood transfusion | ||||
| No* | 642 | 28 (4.4%) | ||
| Yes | 45 | 4 (8.9%) | 2.04 | 0.15 |
| Blood transfusion before 1992 | ||||
| No* | 651 | 28 (4.3%) | ||
| Yes | 36 | 4 (11.1%) | 2.58 | 0.08 |
| Injection drug use | ||||
| No* | 661 | 17 (2.6%) | ||
| Yes | 26 | 15 (57.7%) | 22.19 | <0.0001 |
| Intranasal drug use | ||||
| No | 522 | 16 (3.1%) | ||
| Yes | 165 | 16 (9.7%) | 3.13 | 0.0004 |
| Stuck with a needle with blood on it | ||||
| No* | 673 | 26 (3.9%) | ||
| Yes | 14 | 6 (42.9%) | 11.00 | <0.0001 |
| Number of lifetime sex partners | ||||
| <50* | 564 | 21 (3.7%) | ||
| ⩾50 | 123 | 11 (8.9%) | 2.41 | 0.01 |
| Diagnosed with STD | ||||
| No* | 351 | 13 (3.7%) | ||
| Yes | 336 | 19 (5.6%) | 1.51 | 0.23 |
| Exchanged sex for money | ||||
| No | 608 | 23 (3.8%) | ||
| Yes | 79 | 9 (11.4%) | 3.00 | 0.01 |
| Tattoo | ||||
| No | 489 | 23 (4.7%) | ||
| Yes | 198 | 9 (4.6%) | 0.98 | 0.93 |
| Body piercing | ||||
| No | 484 | 21 (4.3%) | ||
| Yes | 203 | 11 (5.4%) | 1.26 | 0.54 |
| Injected vitamins or medications with used needles | ||||
| No* | 673 | 31 (4.6%) | ||
| Yes | 14 | 1 (7.1%) | 1.54 | 0.49 |
| Injected vitamins or medications outside US | ||||
| No* | 433 | 24 (5.5%) | ||
| Yes | 254 | 8 (3.2%) | 0.58 | 0.15 |
| History of prison or jail for ⩾1 days | ||||
| No | 417 | 7 (1.7%) | ||
| Yes | 270 | 25 (9.3%) | 5.47 | <0.0001 |
| Household contact with HCV+ person | ||||
| No* | 666 | 28 (4.2%) | ||
| Yes | 21 | 4 (19%) | 4.52 | 0.01 |
| Sexual contact with HCV+ person | ||||
| No* | 677 | 28 (4.1%) | ||
| Yes | 10 | 4 (40.0%) | 9.76 | <0.0001 |
| Ever been told HIV+ | ||||
| No* | 665 | 30 (4.5%) | ||
| Yes | 22 | 2 (9.1%) | 2.02 | 0.28 |